<unk> (topical) is an immunosuppressive agent that is FDA approved for the treatment of moderate to severe atopic dermatitis, prophylaxis of cardiac transplant rejection, liver transplant rejection, renal transplant rejection.   Common adverse reactions include peripheral edema, alopecia, persistent erythema of skin, pruritus, rash, constipation, diarrhea, nausea, vomiting, anemia, leukocytosis, thrombocytopenia, headache, insomnia, paresthesia, and tremor.
Tacrolimus 
Sirolimus
Temsirolimus
Pimecrolimus
Aldesleukin
Ruxolitinib
Interferon alfa-2b
Interferon alfa-2a